Target intelligence / Profile preview

Zinc finger MYM-type 4 pseudogene

Molecular classification
Pseudogene, Other
01

Overview

Zinc finger MYM-type 4 pseudogene" (ENSG00000264930) is a **pseudogene** annotated in the Ensembl database. Pseudogenes, by definition, are *genomic DNA sequences similar to normal genes but nonfunctional*; they generally do not encode proteins due to mutations or truncations that prevent translation or result in nonfunctional products.\nThe symbol ENSG00000264930 specifically identifies a pseudogene related to "zinc finger MYM-type 4"—also known as **ZMYM4**—but it does not encode a functional ZMYM4 protein. Functional ZMYM4 (Ensembl: ENSG00000146463) is a MYM-type zinc finger protein involved in DNA binding, cytoskeletal organization, and regulation of cell morphology, with links to cellular proliferation and possible roles in disease, but that function and disease involvement do **not** pertain to the pseudogene form[3][1][2].\nAs a pseudogene, ENSG00000264930 is **not considered a therapeutic target**, has no drug interactions or mechanism of action, and has no known biomarker or disease role.\n\n**Key clarification**:\n- There is a functional protein-coding gene called *Zinc finger MYM-type containing 4* (**ZMYM4**, ENSG00000146463) with real protein and possible disease relevance[3][1][2].\n- ENSG00000264930 refers to a **pseudogene**, not a protein-coding gene, and is not a drug target.\n- If a therapeutic target is intended, the appropriate entry should reference the functional ZMYM4 gene, not the pseudogene.\n\n**Summary:** ENSG00000264930 designates a non-functional pseudogene version of ZMYM4 and should not be considered a valid therapeutic target for drug discovery or intervention.

Other names
ZMYM4PZNF262P

Beyond the preview

Go deeper on Zinc finger MYM-type 4 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger MYM-type 4 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call